High 10 Startup and Tech Funding Information – July 31, 2025

Ramp Raises $500M Sequence E-2 Funding to Increase AI-Powered Finance Platform

Ramp, a New York-based expense administration fintech startup, has raised a hefty $500 million in a Series E-2 round to speed up its AI-driven company finance instruments. The funding, which values Ramp at $22.5 billion, was led by Iconiq Capital with participation from current traders, together with Founders Fund, D1 Capital.

Coming simply weeks after a previous funding, this new infusion will gasoline Ramp’s growth of “finance co-pilot” AI brokers geared toward automating expense reporting, invoice pay, and different back-office duties for its 40,000 enterprise clients.

Based in 2019 by Eric Glyman, Gene Lee, and Karim Atiyeh, Ramp started with a easy pitch: assist firms get monetary savings. What began as a company card platform has quietly grown into one thing a lot greater—a monetary stack that handles the whole lot from journey and bookkeeping to invoice pay and vendor procurement.

Funding Particulars:

• Startup: Ramp

• Traders: Iconiq Capital (lead), Founders Fund, D1 Capital, amongst others.

• Quantity Raised: $500 million

• Complete Raised: $1.9 billion

• Funding Stage: Sequence E-2

• Funding Date: July 30, 2025

MapLight Therapeutics Secures $372.5M in Sequence D Funding for Neuroscience Drug Pipeline

MapLight Therapeutics, a California biotech startup concentrating on mind and central nervous system issues, landed a colossal $372.5 million Sequence D spherical to advance its neuroscience drug pipeline. The financing was co-led by Forbion and Goldman Sachs’ life sciences arm, and introduced in strategic pharma backers together with Sanofi and T. Rowe Worth.

The brand new capital positions MapLight to push its lead schizophrenia therapy by means of Section 2 trials and scale up manufacturing, because the startup goals to problem established neuropharmaceutical therapies.

“With this financing, MapLight will advance ML-007C-MA by means of ongoing Section 2 trials for schizophrenia and Alzheimer’s illness psychosis. The financing may even fund the exploration of different potential indications for ML-007C-MA, in addition to the continued development of different medical and preclinical pipeline applications,” the corporate mentioned in a news release.

Funding Particulars:

• Startup: MapLight Therapeutics

• Traders: Forbion and Goldman Sachs Alternate options (co-leads); participation from Sanofi, T. Rowe Worth, Avego Capital; current traders Novo Holdings, 5AM Ventures, Blue Owl, others

• Quantity Raised: $372.5 million

• Complete Raised: Not disclosed

• Funding Stage: Sequence D

• Funding Date: July 28, 2025

Apptronik Attracts $350M in Sequence A Funding to Construct Humanoid Robots

Austin-based Apptronik, a College of Texas spinout making humanoid robots, secured $350 million in a large Sequence A spherical to scale manufacturing of its Apollo robotic for real-world work. The spherical was co-led by B Capital and Capital Manufacturing unit, with participation from Google (by way of its DeepMind division) as a strategic companion.

Apptronik, which has labored with NASA on robotics, will use the funds to speed up manufacturing and deployment of its AI-powered humanoids, aiming to place them to make use of in logistics and industrial settings by 2026.

Funding Particulars:

• Startup: Apptronik

• Traders: B Capital and Capital Manufacturing unit (co-leads); participation from Google’s DeepMind

• Quantity Raised: $350 million

• Complete Raised: ~$378 million

• Funding Stage: Sequence A

• Funding Date: July 31, 2025

Observe Raises $156M in Funding to Enhance Observability in an Period of Nonstop Software program Releases

Observe, a San Mateo-based software program startup, raised $156 million in new funding to problem monitoring giants like Datadog and Splunk with its AI-powered observability platform. Sutter Hill Ventures led the Sequence C spherical, joined by Madrona Ventures, Alumni Ventures, and the enterprise arms of Snowflake and Capital One.

Observe’s platform centralizes logs, metrics, and traces on a Snowflake information lake to simplify troubleshooting of complicated software program methods. With ~100 enterprise clients and speedy income progress, the corporate will use the capital to boost its product (together with natural-language AI assistants) and develop its crew for a broader North American attain.

Observe is an observability platform based in 2017 with the thought of streamlining how firms troubleshoot issues throughout their software program stacks. As firms started delivery updates quicker and extra usually, the amount of information generated skyrocketed—creating new challenges in monitoring system conduct and pinpointing failures. Observe got down to make sense of that chaos.

Funding Particulars:

• Startup: Observe

• Traders: Sutter Hill Ventures (lead); Madrona Ventures, Alumni Ventures, Snowflake Ventures, Capital One Ventures.

• Quantity Raised: $156 million

• Complete Raised: Over $270 million

• Funding Stage: Sequence C

• Funding Date: July 30, 2025

Anaconda Snags $150M in Sequence C  Funding to Increase Open-Supply AI Instruments

Anaconda, a supplier of open-source Python software program for information science and AI, has raised $150 million in a Series C round led by Perception Companions. Abu Dhabi’s Mubadala Capital additionally participated in a deal that reportedly values the Austin-based firm at $1.5 billion.

Anaconda mentioned the recent funds will assist product improvement, potential acquisitions, and worldwide growth of its platform, which is extensively utilized by enterprises for AI and machine studying improvement. The funding comes amid surging demand for AI developer instruments as organizations shift to broader AI purposes.

Anaconda was based in 2012 by Peter Wang and Travis Oliphant to make Python extra accessible for enterprise information analytics. Since then, Python has turn out to be essentially the most extensively used programming language on the earth—and Anaconda has grown alongside it. The corporate now employs greater than 300 folks globally and helps a consumer base of over 40 million.

Funding Particulars:

• Startup: Anaconda

• Traders: Perception Companions (lead), Mubadala Capital

• Quantity Raised: $150 million

• Complete Raised: Not disclosed

• Funding Stage: Sequence C

• Funding Date: July 31, 2025

Artbio Raises $132M in Sequence B Funding to Advance Most cancers Radiotherapies

Artbio, a radiopharmaceutical startup creating alpha-particle therapies for most cancers, secured $132 million in Sequence B funding to speed up its lead drug program. The spherical was co-led by Sofinnova Investments and B Capital, with participation from current traders F-Prime Capital, Omega Funds, Third Rock Ventures, and new backers together with Qatar Funding Authority (QIA) and Alexandria Enterprise Investments.

Primarily based within the U.S., Artbio will use the funds to push its lead prostate most cancers therapy by means of Section 2 trials and to scale up its radioisotope manufacturing community in preparation for later-stage improvement..

Funding Particulars:

• Startup: Artbio

• Traders: Sofinnova Investments and B Capital (co-leads); current traders F-Prime, Omega Funds, Third Rock, with new traders Qatar Funding Authority and Alexandria Enterprise Investments

• Quantity Raised: $132 million

• Complete Raised: Not disclosed

• Funding Stage: Sequence B

• Funding Date: July 29, 2025

FuriosaAI Lands $125M in Funding to Scale Vitality-Environment friendly AI Chips

FuriosaAI, a Seoul-based AI semiconductor startup, has closed a $125 million Series C bridge funding round to ramp up manufacturing of its next-gen AI inference chips. The increase was supported by main Korean traders like Korea Growth Financial institution, Industrial Financial institution of Korea, Keistone Companions, and Kakao Funding.

Furiosa’s {hardware} (“RNGD” accelerators) guarantees greater effectivity for working giant AI fashions. With this infusion – which brings its complete funding to $246 million and a valuation of roughly $735 million – FuriosaAI plans to scale up manufacturing globally and develop its subsequent chip era, tackling the facility and price constraints of immediately’s GPU-based AI infrastructure.

Based in 2017, FuriosaAI is a semiconductor startup constructing AI chips particularly for information facilities and enterprise inference workloads. Reasonably than iterate on current designs, the corporate rethinks each {hardware} and software program from the bottom as much as allow extra sustainable and scalable AI computing.

Funding Particulars:

• Startup: FuriosaAI

• Traders: Korea Growth Financial institution, Industrial Financial institution of Korea, Keistone Companions, Kakao Funding (amongst others)

• Quantity Raised: $125 million

• Complete Raised: $246 million

• Funding Stage: Sequence C (bridge)

• Funding Date: July 30, 2025

Noma Safety Grabs $100M in Sequence B Funding to Defend AI Techniques from Cyber Threats

Noma Security, an Israeli cybersecurity startup whose platform secures enterprise information and AI fashions towards malicious “AI brokers,” has raised $100 million in a Series B round. The funding was led by U.S.-based Evolution Fairness Companions, with continued participation from Ballistic Ventures and Israel’s Glilot Capital.

The spherical brings Noma’s complete funding to $132 million to this point. Noma plans to make use of the capital to increase its operations throughout North America, Europe, the Center East, and Africa, and to develop its R&D crew in Tel Aviv as cyber threats towards AI methods rise.

Noma Safety emerged from stealth in November 2024 and shortly gained traction, ending the yr with a sturdy base of enterprise clients already in manufacturing. Over the previous yr, the corporate grew its annual recurring income (ARR) by greater than 1,300%, securing dozens of deployments throughout monetary companies, life sciences, retail, and huge tech corporations.

The brand new funding arrives at a pivotal second for enterprise CISOs, who’re below rising strain to safe and govern agentic AI methods earlier than widespread adoption. UBS Analysis studies that 53% of organizations plan to implement agentic AI by 2026, with that quantity rising to 83% by 2028.

Funding Particulars:

• Startup: Noma Safety

• Traders: Evolution Fairness Companions (lead), Ballistic Ventures, Glilot Capital

• Quantity Raised: $100 million

• Complete Raised: $132 million

• Funding Stage: Sequence B

• Funding Date: July 31, 2025

Ultromics Diagnoses $55M in Sequence C Funding for AI Coronary heart Scans

Ultromics, an Oxford, UK-based healthtech utilizing AI to detect coronary heart illness from ultrasounds, raised $55 million in Sequence C funding to increase its platform throughout the U.S. healthcare system. The spherical was co-led by Authorized & Common, Allegis Capital, and Lightrock with extra assist from Oxford Science Enterprises, GV (Google Ventures), Blue Enterprise Fund, and others.

Ultromics’ FDA-cleared EchoGo software program makes use of AI to investigate echocardiograms for early indicators of coronary heart failure. The brand new funding will assist deploy EchoGo at scale in hospitals and clinics, develop the corporate’s product pipeline, and forge extra partnerships with healthcare suppliers to enhance cardiovascular outcomes.

Funding Particulars:

• Startup: Ultromics

• Traders: Authorized & Common, Allegis Capital, and Lightrock (co-leads); participation from Oxford Science Enterprises, GV (Google Ventures), Blue Enterprise Fund, UCM Ventures, UPMC Enterprises

• Quantity Raised: $55 million

• Complete Raised: Not disclosed

• Funding Stage: Sequence C

• Funding Date: July 31, 2025

Delian Alliance Industries Raises $14M in Funding to Scale Autonomous Protection Techniques

Delian Alliance Industries, an Athens-based protection tech startup based by ex-Apple engineer Dimitrios Kottas, has raised $14 million in Sequence A funding to develop autonomous military-grade methods. The spherical was co-led by Air Avenue Capital and Marathon Enterprise Capital, with participation from 201 Ventures, HCVC, Entropy Industrial Capital, and Nebular.

Delian Alliance is constructing AI-powered protection platforms – comparable to drones and surveillance towers – amid rising demand for cutting-edge safety tech in Europe. The corporate says it would use the funds to increase its engineering and discipline deployment groups and speed up manufacturing to fulfill curiosity from NATO companions and different allied protection organizations.

Funding Particulars:

• Startup: Delian Alliance Industries

• Traders: Air Avenue Capital and Marathon VC (co-leads); 201 Ventures, HCVC, Entropy Industrial Capital, Nebular

• Quantity Raised: $14 million

• Complete Raised: ~ $20 million

• Funding Stage: Sequence A

• Funding Date: July 29, 2025

Tech Funding Abstract Desk